Home > PS Ratio > INDOCO REMEDIES

INDOCO REMEDIES
PS (Price/Sales) Ratio

The Current P/S Ratio of INDOCO REMEDIES is 1.88.

Share Price ₹339.7Jul 03,2025
Market Cap ₹3,132.0 Cr
Sales-TTM₹1,664.9 CrTTM-Consolidated Results
Price/Sales1.88xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of INDOCO REMEDIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of INDOCO REMEDIES is calculated as :

Current Market Cap [ ₹3,132.0 Cr] as on Jul 03,2025

(/) Sales [ ₹1,664.9 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 1.88x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for INDOCO REMEDIES , the investors are currently willing to pay '1.88 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of INDOCO REMEDIES !

The chart below summarizes the trend in P/S Ratio of INDOCO REMEDIES over the last five years.

Historical PS (Price/Sales) ratio chart of INDOCO REMEDIES


PS Ratio Performance Analysis for INDOCO REMEDIES

- INDOCO REMEDIES 's latest p/e ratio is 1.88x.

- INDOCO REMEDIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.92x.

- INDOCO REMEDIES 's operated at median p/e ratio of 1.8x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, INDOCO REMEDIES 's p/e ratio peaked in Mar2022 at 2.25x.

- INDOCO REMEDIES 's p/e ratio hit its five-year low in Mar2024 of 1.67x.


How does INDOCO REMEDIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
INDOCO REMEDIES 1,664.91.883,132.0
SUN PHARMACEUTICAL INDUSTRIES LTD52,578.47.66402,788.0
DIVIS LABORATORIES LTD9,360.019.47182,283.0
CIPLA LTD27,547.64.42121,853.0
TORRENT PHARMACEUTICALS LTD11,516.09.80112,914.0
DR REDDYS LABORATORIES LTD32,643.93.31107,932.0
MANKIND PHARMA LTD12,279.37.9497,548.4
ZYDUS LIFESCIENCES LTD23,241.54.33100,563.0
LUPIN LTD22,707.93.9389,315.4
AUROBINDO PHARMA LTD31,723.72.1267,114.5
ABBOTT INDIA LTD6,409.211.7675,397.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs INDOCO REMEDIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 1.88x
Max industry PS 19.47x
Median industry PS 4.42x
Average industry PS 6.97x



You may also like the below Video Courses